title: Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder.
authors: a Department of Internal Medicine , Division of Medical Oncology, University Hospital Basel , Switzerland .|b Department of Biomedicine , Cancer Immunology Laboratory, University Hospital Basel , Switzerland .
authors: Heinz
authors: H
authors: Läubli
authors: c Institute of Pathology, University Hospital Basel , Switzerland , and.
authors: Alexandar
authors: A
authors: Tzankov
authors: c Institute of Pathology, University Hospital Basel , Switzerland , and.
authors: Darius
authors: D
authors: Juskevicius
authors: d Division of Gastroenterology and Hepatology, University Hospital Basel , Switzerland.
authors: Lukas
authors: L
authors: Degen
authors: a Department of Internal Medicine , Division of Medical Oncology, University Hospital Basel , Switzerland .
authors: Christoph
authors: C
authors: Rochlitz
authors: a Department of Internal Medicine , Division of Medical Oncology, University Hospital Basel , Switzerland .|b Department of Biomedicine , Cancer Immunology Laboratory, University Hospital Basel , Switzerland .
authors: Frank
authors: F
authors: Stenner-Liewen
mesh_terms: D000328:Adult; D001402:B-Lymphocytes / Q000473:pathology*; D001706:Biopsy; D020031:Epstein-Barr Virus Infections / Q000150:complications; D005260:Female; D023281:Genomics / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007150:Immunohistochemistry; D000077269:Lenalidomide; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide